Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye

Trial Profile

Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jan 2016

At a glance

  • Drugs Thymosin-beta-4 (Primary)
  • Indications Dry eyes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Dec 2015 According to a RegeneRx Biopharmaceuticals media release. the final results of this trial have been posted on clinicaltrials.gov.
    • 22 Dec 2015 Protocol has been amended in change in study design from single to parallel assignment, number of treatment arms from 1 to 2 and change in trial focus from TU to AR. However both TU and AR is retained in CTP as result is already published.
    • 10 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top